Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Immunol Res ; 70(1): 44-55, 2022 02.
Article in English | MEDLINE | ID: mdl-34618307

ABSTRACT

Primary antibody deficiencies (PAD) are the most common subtype of primary immunodeficiencies, characterized by increased susceptibility to infections and autoimmunity, allergy, or malignancy predisposition. PAD syndromes comprise of immune system genes highlighted the key role of B cell activation, proliferation, migration, somatic hypermutation, or isotype switching have a wide spectrum from agammaglobulinemia to selective Ig deficiency. In this study, we describe the molecular and the clinical aspects of fifty-two PAD patients. The most common symptoms of our cohort were upper and lower respiratory infections, bronchiectasis, diarrhea, and recurrent fever. Almost all patients (98%) had at least one of the symptoms like autoimmunity, lymphoproliferation, allergy, or gastrointestinal disease. A custom-made next-generation sequencing (NGS) panel, which contains 24 genes, was designed to identify well-known disease-causing variants in our cohort. We identified eight variants (15.4%) among 52 PAD patients. The variants mapped to BTK (n = 4), CD40L (n = 1), ICOS (n = 1), IGHM (n = 1), and TCF3 (n = 1) genes. Three novel variants were described in the BTK (p.G414W), ICOS (p.G60*), and IGHM (p.S19*) genes. We performed Sanger sequencing to validate pathogenic variants and check for allelic segregation in the family. Targeted NGS panel sequencing can be beneficial as a suitable diagnostic modality for diagnosing well-known monogenic PAD diseases (only 2-10% of PADs); however, screening only the coding regions of the genome may not be adequately powered to solve the pathogenesis of PAD in all cases. Deciphering the regulatory regions of the genome and better understanding the epigenetic modifications will elucidate the molecular basis of complex PADs.


Subject(s)
Agammaglobulinemia , Hypersensitivity , Primary Immunodeficiency Diseases , Agammaglobulinemia/diagnosis , Agammaglobulinemia/genetics , High-Throughput Nucleotide Sequencing , Humans , Turkey/epidemiology
3.
Children (Basel) ; 4(10)2017 Oct 19.
Article in English | MEDLINE | ID: mdl-29048383

ABSTRACT

Although intussusception and food allergy are common health problems in childhood, the relation between these two diseases remain obscure. The aim of this study is to investigate the relationship between food allergy and intussusception, and the factors associated with both. Patients diagnosed with intussusception by the Brighton Collaboration Intussusception Working Group criteria were prospectively investigated for food allergy per the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Guideline. They were analyzed per demographic features, clinical, physical and laboratory findings. There were eight (38.1%) patients diagnosed with food allergy, while 13 (61.9%) patients were non-allergic. The mean number of days of presenting symptoms was 1.13 days in the allergy group and 7.85 days in the non-allergy group. The mean number of intussusception attacks was 1.63 in the allergy group while 1 in the non-allergy group (p < 0.05, relative risk (RR) = 2.6). In the allergy group, one (13%) patient was followed up, six (75%) patients were reduced with pneumatic and one (13%) patient reduced manually. In the non-allergy group, four (31%) patients were followed up, six (46%) patients were reduced with pneumotic, one (7%) patient was reduced manually, and resection anastomosis was performed in two (15%) patients. Food allergy is an unrecognized associated factor for intussusception patients, which increases the risk for recurrence. Due to the small patient population, these results should be interpreted with caution.

4.
Med Hypotheses ; 77(2): 261-2, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21570198

ABSTRACT

The suicide rates among asthmatic patients are higher than among the general population. Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family and is strongly associated with suicide pathogenesis. BDNF also plays an important role in neuroimmune reactions in allergic diseases such as asthma. Therefore, we hypothesize that alterations of BDNF levels in the brain may explain the increased suicide rates among asthmatic patients.


Subject(s)
Asthma/complications , Asthma/immunology , Brain-Derived Neurotrophic Factor/immunology , Brain-Derived Neurotrophic Factor/metabolism , Neurons/physiology , Suicide , Synapses/physiology , Brain-Derived Neurotrophic Factor/blood , Hippocampus/metabolism , Humans , Neurons/cytology , Prefrontal Cortex/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...